Related Experiment Video
Updated: Jun 28, 2026
07:50
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
New jasmonate analogues as potential anti-inflammatory agents
Hung The Dang1, Hye Ja Lee, Eun Sook Yoo
1College of Pharmacy, Pusan National University, Geumjeong-gu, Busan 609-735, Republic of Korea.
Bioorganic & Medicinal Chemistry
|November 11, 2008
Summary
New research explores methyl jasmonate analogues as potential anti-inflammatory agents. Certain alpha-haloenone derivatives show significant promise in inhibiting pro-inflammatory mediators in macrophage cells.
Area of Science:
- Medicinal Chemistry
- Immunology
- Pharmacology
Background:
- Inflammation is a key process in many diseases.
- Current anti-inflammatory treatments have limitations.
- Jasmonate derivatives are underexplored for anti-inflammatory potential.
Purpose of the Study:
- To synthesize and evaluate methyl jasmonate analogues for anti-inflammatory activity.
- To investigate the effect of structural modifications on potency and safety.
- To identify novel lead compounds for anti-inflammatory drug development.
Main Methods:
- Synthesis of methyl jasmonate analogues (compounds 2-20).
- Evaluation of inhibitory effects on nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) production.
- Assessment in lipopolysaccharide (LPS)-activated RAW264.7 murine macrophage cells.
- Comparison with natural anti-inflammatory prostaglandins.
Main Results:
- Introduction of an enone functionality (compound 2) yielded significant anti-inflammatory activity.
- Analogues 7, 9, 13, and 15 displayed enhanced potency compared to compound 2.
- Compounds 9 and 15 showed the highest potency; compounds 7 and 13 offered a better safety profile.
- Alpha-haloenone jasmonates demonstrated greater potency than natural prostaglandins.
Conclusions:
- This study is the first to demonstrate the anti-inflammatory potential of jasmonate derivatives.
- Alpha-haloenone jasmonates (7, 9, 13, and 15) are promising lead compounds for developing new anti-inflammatory agents.
- Further research into these compounds could lead to novel therapeutic strategies for inflammatory diseases.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms: